Cresilon has filed a notice of an exempt offering of securities to raise $38,006,240.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Cresilon is raising up to $38,006,240.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Scott Levine played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Cresilon
Headquartered in Brooklyn, New York, Cresilon, Inc. is a privately-held medical device company focused on hemostatic technologies that improve wound care and advance the standard of medical treatments. For more information, visit Cresilon.com. We are always looking for dynamic people to join our team as we dive into a range of challenges at the forefront of science and technology.
To learn more about Cresilon, visit http://cresilon.com/
Cresilon Linkedin Page: https://www.linkedin.com/company/cresilon/
Contact:
Scott Levine, Chief Financial Officer
347-435-2226
https://www.linkedin.com/in/scott-levine-cpa-9a2a532/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.